Literature DB >> 3544787

Status of risk factors and their consideration in antihypertensive therapy.

W B Kannel.   

Abstract

Risk factors for cardiovascular disease include atherogenic personal attributes, living habits that promote them, signs of preclinical disease and host susceptibility. Atherogenic traits include the blood lipids, blood pressure and glucose tolerance. An increased low density lipoprotein cholesterol level is positively related, and an increased high density lipoprotein cholesterol level is inversely related, to cardiovascular disease incidence. Hypertension, whether systolic or diastolic, labile or fixed, casual or basal, at any age in either sex contributes greatly. The impact of diabetes is greater for women than men and varies depending on the level of the foregoing risk factors. An atherogenic lifestyle is typified by a diet excessive in calories, fat and salt, sedentary habits, unrestrained weight gain and smoking. Alcohol used in moderation may be beneficial. Oral contraceptives worsen atherogenic traits and, when used for long periods beyond age 35 and in conjunction with cigarettes, predispose to thromboembolism. Type A persons with an overdeveloped sense of time urgency, drive and competitiveness develop an excess of angina pectoris. Men married to more highly educated women are at increased risk as are men married to women in white collar jobs. Preclinical signs of compromised coronary circulation include silent myocardial infarction, left ventricular hypertrophy on the electrocardiogram, blocked intraventricular conduction and repolarization abnormalities. An electrocardiogram obtained during exercise may elicit still earlier evidence. Measures of innate susceptibility include a family history, history of premature cardiovascular disease, diabetes, hypertension and gout. Optimal prediction of risk requires a quantitative combination of risk factors in multiple logistic risk formulations to identify high risk persons with multiple marginal abnormalities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3544787     DOI: 10.1016/0002-9149(87)90182-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Treatment of hypertension in the elderly.

Authors:  W H Birkenhäger; P W de Leeuw; A Amery; J Staessen
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

2.  Clinical aspects of antihypertensive therapy with urapidil. Comparison with hydrochlorothiazide.

Authors:  A Distler; R Haerlin; G Hilgenstock; J Passfall
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: a population-based follow-up study in the Skaraborg Project.

Authors:  Erik Bøg-Hansen; Charlotte A Larsson; Bo Gullberg; Arne Melander; Kristina Boström; Lennart Råstam; Ulf Lindblad
Journal:  Scand J Prim Health Care       Date:  2007-12       Impact factor: 2.581

4.  Alterations of serum cholesterol and serum lipoprotein in breast cancer of women.

Authors:  Kiran Hasija; Hardeep K Bagga
Journal:  Indian J Clin Biochem       Date:  2005-01

5.  Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project.

Authors:  U Lindblad; L Råstam; L Rydén; J Ranstam; S O Isacsson; G Berglund
Journal:  BMJ       Date:  1994-03-12

6.  Decellularization and antibody staining of mouse tissues to map native extracellular matrix structures in 3D.

Authors:  Alejandro E Mayorca-Guiliani; Oliver Willacy; Raphael Reuten; Chris D Madsen; Maria Rafaeva; Stefanie Elisabeth Heumüller; Felix Bock; Gerhard Sengle; Manuel Koch; Thomas Imhof; Frank Zaucke; Raimund Wagener; Takako Sasaki; Janine T Erler
Journal:  Nat Protoc       Date:  2019-11-08       Impact factor: 13.491

7.  Comparison of Serum Lipid Profiles between Normal Controls and Breast Cancer Patients.

Authors:  Pikul Laisupasin; Warayupa Thompat; Saowakon Sukarayodhin; Adisak Sornprom; Yuttana Sudjaroen
Journal:  J Lab Physicians       Date:  2013-01

Review 8.  Molecular alterations critical to the development of arteriosclerotic plaques: a role for environmental agents.

Authors:  A Penn
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.